Children's Oncology Group's 2013 blueprint for research: Non-Hodgkin lymphoma-Reference-Cited by-同舟云学术

Children's Oncology Group's 2013 blueprint for research: Non-Hodgkin lymphoma

Published:2012-12-19 Issue:6 Volume:60 Page:979-984
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr. Blood Cancer

Author:

Bollard Catherine M.,Lim Megan S.,Gross Thomas G.,

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pbc.24416/fullpdf

Reference59 articles.

1. Single-drug vinblastine as salvage treatment for refractory or relapsed anaplastic large-cell lymphoma: A report from the French Society of Pediatric Oncology;Brugieres;J Clin Oncol,2009

2. The immunodeficiency cancer registry A research resource;Filipovich;Am J Pediatr Hematol Oncol,1987

3. Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: A BFM group report;Reiter;Blood,2000

4. Minimal disseminated disease in childhood T-cell lymphoblastic lymphoma: A report from the children's oncology group;Coustan-Smith;J Clin Oncol,2009

5. Effective treatment of advanced-stage childhood lymphoblastic lymphoma without prophylactic cranial irradiation: Results of St Jude NHL13 study;Sandlund;Leukemia,2009

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Allogeneic hematopoietic stem cell transplantation for relapsed/refractory non-Hodgkin lymphomas;Pediatric Hematology/Oncology and Immunopathology;2024-04-08

2. Children's Oncology Group's 2023 blueprint for research: Non‐Hodgkin lymphoma;Pediatric Blood & Cancer;2023-07-14

3. B cell subsets reconstitution and immunoglobulin levels in children and adolescents with B non-Hodgkin lymphoma after treatment with single anti CD20 agent dose included in chemotherapeutic protocols: single center experience and review of the literature;Biomedical Papers;2023-05-23

4. Principles of Monoclonal and Small Molecular Targeting Agents for Pediatric Cancer Management;Pediatric Surgical Oncology;2023

5. Clinical course, long-term outcomes, and Chemotherapy toxicity profile in B-cell Non-Hodgkin Lymphoma in children: single institution experience of Pakistan;Journal of the Pakistan Medical Association;2022-09-15